CardioGenics (CGNH) 10-Q2011 Q0 Quarterly report

Filed: 17 Mar 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: aim, al, alleged, announced, attach, attorney, batch, bead, captioned, cent, clause, coated, coating, complaint, context, core, decided, discovery, distributor, doctrine, encapsulated, encapsulation, enforceable, failure, favor, finalizing, forum, fraud, furnish, greater, Intellectual, IVD, Karver, litigated, litigation, mailed, MTA, nearest, ninety, notified, personal, Plaintiff, plead, polymer, Property, recovery, redeem, redeemed, Redemption, refining, rounded, SAS, successor, technical, top, Transfer, withdraw

Removed: absence, Advance, agreed, allocated, allocating, amended, arrangement, attributed, authoritative, beneficial, beneficially, Bloomberg, borrowing, Bulletin, calculated, carried, carry, cease, charge, charged, classified, combined, Commencement, commitment, complex, component, concluding, concurrent, conform, consultant, converted, credited, debenture, declared, decrease, deliverable, derivative, determination, determined, disclosed, disposed, distinguished, divested, Earlier, entitling, entity, Euronext, event, evidence, exceed, execution, existed, fact, force, forma, Global, hierarchy, iii, impact, indexed, insignificant, issuable, issuance, liability, limitation, loan, lowest, manner, Master, maximize, met, minimal, modified, multiple, NASDAQ, nonconvertible, Note, notice, NYSE, objective, obligation, officer, optional, OTC, parent, part, Partial, permanently, portion, potentially, presentation, Principal, prohibited, pronounced, pronouncement, prospectively, provision, purpose, quotation, reclassified, record, register, Registrable, remaining, request, residual, resold, retrospective, sale, SEDA, Select, selling, separate, separately, September, set, settle, settled, similar, single, Specifically, SPV, standard, Standby, type, unissued, unusual, valuation, vendor, volume, VWAP, wholly, written, YA, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CGNH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Section 906 Certification by the Chief Executive Officer and Chief Financial Officer

Each of Yahia Gawad, Chief Executive Officer, and James Essex, Chief Financial Officer, of CardioGenics Holdings Inc., a Nevada corporation (the “Company”) hereby certifies pursuant to 18 U.S.C. ss. 1350, as added by ss. 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge:

(1) The Company’s periodic report on Form 10-Q for the period ended January 31, 2011 (“Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operation of the Company.

/s/ Yahia Gawad		/s/ James Essex

Name: Yahia Gawad		Name: James Essex
Title: Chief Executive Officer		Title: Chief Financial Officer

Date: March 17, 2011